Literature DB >> 17911340

Common and specific effects of the two major forms of prolactin in the rat testis.

Valencia L Williams1, Ariel DeGuzman, Hong Dang, Mitsumori Kawaminami, Timothy W C Ho, David G Carter, Ameae M Walker.   

Abstract

Prolactin (PRL) has both stimulatory and inhibitory effects on testicular function, a finding we hypothesized may be related in some part to the form of the hormone present or administered. In the analysis of the pituitary secretion profiles of early pubescent vs. mature male rats, we found PRL released from early pubescent pituitaries had about twice the degree of phosphorylation. Treatment of mature males with either unmodified PRL (U-PRL) or phosphorylated PRL (via the molecular mimic S179D PRL) for a period of 4 wk (circulating level of approximately 50 ng/ml) showed serum testosterone decreased by approximately 35% only by treatment with the phospho-mimic S179D PRL. Given the specificity of this effect, it was initially surprising that both forms of PRL decreased testicular expression of 3beta-hydroxysteroid dehydrogenase and steroidogenic acute regulatory protein. Both forms also increased expression of the luteinizing hormone receptor, but only S179D PRL increased the ratio of short to long PRL receptors. Endogenous PRL and luteinizing hormone levels were unchanged in all groups in this time frame, suggesting that effects on steroidogenic gene expression were directly on the testis. Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling analysis combined with staining for 3beta-hydroxysteroid dehydrogenase and morphometric analysis showed that S179D PRL, but not U-PRL, increased apoptosis of Leydig cells, a finding supported by increased staining for Fas and Fas ligand in the testicular interstitium, providing an explanation for the specific effect on testosterone. S179D PRL, but not U-PRL, also increased apoptosis of primary spermatogonia, and U-PRL, but not S179D PRL, decreased apoptosis of elongating spermatids. Thus, in mature males, hyperprolactinemic levels of both forms of PRL have common effects on steroidogenic proteins, but specific effects on the apoptosis of Leydig and germ cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17911340      PMCID: PMC7599043          DOI: 10.1152/ajpendo.00541.2007

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  52 in total

1.  Prolactin, growth hormone, and luteinizing hormone in the maintenance of testicular luteinizing hormone receptors.

Authors:  W B Zipf; A H Payne; R P Kelch
Journal:  Endocrinology       Date:  1978-08       Impact factor: 4.736

2.  Glucocorticoid induces apoptosis in rat leydig cells.

Authors:  Hui-Bao Gao; Ming-Han Tong; Yan-Qiang Hu; Qing-Su Guo; Renshan Ge; Matthew P Hardy
Journal:  Endocrinology       Date:  2002-01       Impact factor: 4.736

3.  Bromocriptine for male infertility.

Authors:  K Saidi; R V Wenn; F Sharif
Journal:  Lancet       Date:  1977-01-29       Impact factor: 79.321

4.  A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice.

Authors:  X Xu; E Kreye; C B Kuo; A M Walker
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

5.  Fas and Fas ligand expression in fetal and adult human testis with normal or deranged spermatogenesis.

Authors:  S Francavilla; P D'Abrizio; N Rucci; G Silvano; G Properzi; E Straface; G Cordeschi; S Necozione; L Gnessi; M Arizzi; S Ulisse
Journal:  J Clin Endocrinol Metab       Date:  2000-08       Impact factor: 5.958

6.  Prolactin and Leydig cell responsiveness to LH/hCG in the rat.

Authors:  K Purvis; O P Clausen; A Olsen; E Haug; V Hansson
Journal:  Arch Androl       Date:  1979-11

7.  S179D prolactin primarily uses the extrinsic pathway and mitogen-activated protein kinase signaling to induce apoptosis in human endothelial cells.

Authors:  Eric K Ueda; Hsin-Lung Lo; Paolo Bartolini; Ameae M Walker
Journal:  Endocrinology       Date:  2006-07-13       Impact factor: 4.736

8.  Role of testicular interstitial macrophages in regulating testosterone release in hyperprolactinemia.

Authors:  William J Huang; Jiun-Yih Yeh; Shu-Fen Kan; Luke S Chang; Paulus S Wang
Journal:  J Cell Biochem       Date:  2003-03-01       Impact factor: 4.429

9.  Effects of hyper- and hypoprolactinemia on gonadotropin secretion, rat testicular luteinizing hormone/human chorionic gonadotropin receptors and testosterone production by isolated Leydig cells.

Authors:  C Waeber; O Reymond; M Reymond; T Lemarchand-Beraud
Journal:  Biol Reprod       Date:  1983-02       Impact factor: 4.285

10.  Effects of chronic hyperprolactinemia in mice on plasma gonadotropin concentrations and testicular human chorionic gonadotropin binding sites.

Authors:  H G Klemcke; A Bartke
Journal:  Endocrinology       Date:  1981-05       Impact factor: 4.736

View more
  1 in total

Review 1.  Paradigm-shifters: phosphorylated prolactin and short prolactin receptors.

Authors:  KuangTzu Huang; Eric Ueda; YenHao Chen; Ameae M Walker
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.